SYRAOTCServices-Employment AgenciesFiscal year ends December 31

Syra Health Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$0.83−0.03 (-3.98%)

Close on Oct 19, 2026

Market cap: $11.19M
P/E (TTM): 82.6
Dividend yield: –

Syra Health Corp income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Revenue	7.23	7.98	5.52	5.62
Cost of Revenue	4.74	6.33	4.10	4.56
Gross Profit	2.49	1.65	1.41	1.06
Research & Development	0.07	0.59	0.24	–
Selling, General & Admin	1.07	1.45	1.13	0.58
Operating Expenses	3.39	5.42	4.30	3.15
Operating Income	-0.90	-3.76	-2.89	-2.09
Interest Expense	0.01	0.02	0.05	0.03
Interest & Investment Income	0.02	0.02	0.00	0.00
Other Non-Operating Income	0.01	0.01	-0.05	-0.03
Net Income	-0.90	-3.76	-2.94	-2.12
EPS (Basic)(per share)	-0.08	-0.50	-0.60	-0.70
EPS (Diluted)(per share)	-0.08	-0.50	-0.60	-0.70
Shares Outstanding (Basic, Weighted)(shares)	12	7.55	4.88	3.04
Shares Outstanding (Diluted, Weighted)(shares)	12	7.55	4.88	3.04

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 39.3%
Operating margin: 0.9%
Net margin: 1.6%
Return on equity, FY2025: -36.0%

Financial strength

Current ratio: 3.13
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 177.5%

Valuation

P/E ratio: 82.6
Price to sales: 1.38
Price to book: 4.25
Dividend yield: –